Skip to content
Clinical Trial Services - Criterium - Global CROLearn More

Learn how IRT and remote monitoring keep trials running smoothly

Coronavirus and Clinical Trials:
Criterium Technology ensures that research never stops

Criterium - Clinical Trials - CRO

Get To Know Us!

We are the Premier Hands-on CRO

Therapeutic Areas - Clinical Trial CRO - Criterium

Get To Know Us!

We are the Premier Hands-on CRO

Criterium Global CRO - Clinical Trial Services, Clinical Research

Get To Know Us!

We are the Premier Hands-on CRO

Innovative Clinical Research Solutions

- Since 1991 -

Full-Service, Dedicated, Data Driven – from “Thought to Finish”, Every Trial, Every Time.

Our Competitive Edge

Consider it Done!

Clinical Trial Services - Criterium - Clinical Trials - CRO

Clinical Trial Services

High level of expertise & high-value technology for every trial

Core Science Solutions - Criterium - Clinical Trials - CRO

CORE Science Solutions

Our Unique Centralized Network Model (CNM) for Translational Research

Technology - Criterium - Clinical Trials - CRO

Criterium Technology

Clinical Development tailored to each client’s needs

IVR IWR ePRO - Criterium - Clinical Trials - CRO

IVR/IWR & ePRO

Seamless interfacing with ancillary support technologies

Our Specialty Translational Research Oncology Consortia

Our Flagship Research Division, comprised of Top Universities in USA and Canada

GI Cancer Consortium

GI Cancer Consortium

Providing expertise and innovative solutions for the rapid design, implementation, management and completion of complex GI cancer trials.
Learn More

Myeloma Consortium

Myeloma Consortium

A full service research model that has combined expertise in carrying out the operational components of oncology clinical research.
Learn More

Breast Cancer Consortium

Breast Cancer Consortium

An innovative research model that has brought together an expert team of institutions and investigators to design clinical trials in breast cancer.
Learn More

Thoracic Oncology Consortium

Thoracic Oncology Consortium

Designing and rapidly completing clinical trials in thoracic and lung cancer with the ultimate goal of identifying new drugs to treat this disease.
Learn More

Therapeutic Areas

Our expertise covers a wide range of clinical indications:

Oncology

Allergy & Asthma

Dermatology

Orthopedics

...more

News & Blog

Positive Trial Data with 100% Safe Delivery
Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhibitor and Efficacy in Majority of Patients Preliminary results from phase 1 clinical trial of WP1220 for treatment of cutaneous T-cell lymphoma (“CTCL”); supports phase 2 study. “For years, p-STAT3 (the activated form of STAT3) has been considered an ‘undruggable’

Meet With Us!